Back

Plasma levels of human growth differentiation factor 15 (GDF-15) and their effect of alirocumab on major adverse cardiovascular events and all-cause death after acute coronary syndrome

1 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Multidimensional approaches to myocardial infarction: from stress impact to breakthrough therapies Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Percutaneous revascularization in late-presenting STEMI with absence of viability: effects on left ventricular remodeling and scar
Doctor B. Valente (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Chronic stress is gradually accumulated and peaks prior the occurrence of Takotsubo Syndrome: preliminary results based on hair cortisol concentration
Doctor D. Iordanidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Circulating nucleases degrade high-molecular-weight cell-free DNA in coronary vessels during acute myocardial infarction
Mr T. Artner (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Relation of plasma neuropeptide-Y with myocardial function and infarct severity in acute ST-elevation myocardial infarction
Doctor C. Tiller (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Nicorandil activates lkb1-ampk signaling pathway to ameliorate cardiac remodeling after myocardial ischemia/reperfusion injury by upregulating mt2
Assistant Professor Q. Lin (Dalian, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Multidimensional approaches to myocardial infarction: from stress impact to breakthrough therapies

The Event

Event poster

ESC Congress 2024

1 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
GDF-15 is associated with worse ischemic and bleeding outcomes in the acute phase and during follow-up in patients with acute coronary syndrome: insights from the TRACER trial
thumbnail
Congress Presentation
Growth differentiation factor-15 and 5-years cardiovascular risk in chest pain patients presenting to the emergency department: a multicenter cohort study
thumbnail
Congress Presentation
Growth differentiation factor 15 and all-cause and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX and EXCEED-J Studies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources